Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 60, No. 4, 2001  

Free Abstract   Article (Fulltext)    Article (PDF 162 KB)     

Laboratory/Clinical Translational Research

Estrogens, Testosterone and Sex Hormone Binding Globulin in Relation to Liver Cancer in Men
Hannah Kupera, Christos Mantzorosb, Pagona Lagioua,c, Anastasia Tzonouc, Rulla Tamimia, Lorelei Muccia, Vassiliki Benetouc, Evangelos Spanosd, Sherri O. Stuvera, Dimitrios Trichopoulosa,c

aDepartment of Epidemiology, Harvard School of Public Health, Boston, Mass., USA,
bDivision of Endocrinology, Beth Israel Deaconess Medical Center, Boston, Mass., USA,
cDepartment of Hygiene and Epidemiology, University of Athens Medical School, Goudi, Athens, Greece,
dBiomed, International Diagnostic Center, Athens, Greece

Address of Corresponding Author

Oncology 2001;60:355-360 (DOI: 10.1159/000058532)


 goto top of page Key Words

  • Estrogen
  • Liver cancer
  • Sex hormone binding globulin
  • Testosterone

 goto top of page Abstract

Objective: Liver disease in men has been associated with an imbalance of serum estradiol and testosterone. We have evaluated whether serum estradiol and testosterone levels are altered in male liver cancer patients as a result of a specific effect of the disease or because of the associated liver damage. Methods: We have performed a hospital-based case-control study in Greece. The study subjects were all men; 73 patients with hepatocellular carcinoma (HCC), 25 with metastatic liver cancer (MLC) patients and 111 control subjects. Serum estradiol, testosterone and sex hormone binding globulin (SHBG) levels were measured for each subject. Data were analyzed by multiple linear regression. Results: Mean serum estradiol levels were significantly higher among HCC patients as well as among patients with MLC compared to controls. Mean serum testosterone levels were significantly lower among HCC patients as well as among patients with MLC compared to controls. The mean SHBG levels did not differ significantly between the groups. After controlling for the degree of liver damage, the elevated serum estradiol and reduced serum testosterone levels among HCC and MLC patients were no longer significant. Conclusions: Changes in sex steroid levels among patients with liver damage are due to the liver damage per se and not to specific disease processes.

Copyright © 2001 S. Karger AG, Basel


 goto top of page Author Contacts

Hannah Kuper
Department of Epidemiology, Harvard School of Public Health
677 Huntington Avenue
Boston, MA 02115 (USA)
Tel. +1 617 432 4560, Fax +1 617 566 7805, E-Mail hkuper@hsph.harvard.edu


 goto top of page Article Information

Number of Print Pages : 6
Number of Figures : 0, Number of Tables : 4, Number of References : 19

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
PubMed ID 11408804
Download Citation



This journal is part of the fourth subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues

Case Reports in Oncology


For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2010 S. Karger AG, Basel